Abstract:Background and objectives: Diet plays critical roles in modulating maternal metabolic health in pregnancy, but is also a source of metabolic-disrupting phthalates and their replacements. We aimed to evaluate whether the effects of better diet quality on favorable maternal metabolic outcomes could be partially explained by lower exposure to phthalates/replacements. Methods: At 13 weeks gestation, 295 Illinois women (enrolled 2015-2018) completed a three-month food frequency questionnaire that we used to calculate the Alternative Healthy Eating Index (AHEI)-2010 to assess diet quality. We quantified 19 metabolites, reflecting exposure to 10 phthalates/replacements, in a pool of five first-morning urine samples collected monthly across pregnancy. We measured 15 metabolic biomarkers in fasting plasma samples collected at 17 weeks gestation, which we reduced to five uncorrelated principal components (PCs), representing adiposity, lipids, cholesterol, inflammation, and growth. We used linear regression to estimate associations of diet quality with [1] phthalates/replacements and [2] metabolic PCs, as well as [3] associations of phthalates/replacements with metabolic PCs. We estimated the proportion of associations between diet quality and metabolic outcomes explained by phthalates/replacements using a causal mediation framework. Results: Overall, every 10-point improvement in AHEI-2010 score was associated with -0.15 (95% CI: -0.27, -0.04) lower adiposity scores, reflecting lower glucose, insulin, C-peptide, leptin, C-reactive protein, but higher adiponectin biomarker levels. Every 10-point increase in diet quality was also associated with 18% (95%CI: 7%, 28%) lower sum of di-2-ethylhexyl terephthalate urinary metabolites (∑DEHTP). Correspondingly, each 18% increase in ∑DEHTP was associated with 0.03 point (95% CI: 0.01, 0.05) higher adiposity PC scores. In mediation analyses, 21% of the inverse relationship between diet quality and adiposity PC scores was explained by lower ∑DEHTP. Conclusions: The favorable impact of diet quality on maternal adiposity biomarkers may be partially attributed to lower metabolite concentrations of DEHTP, a plasticizer allowed to be used in food packaging materials.

Beyond Classic Phthalates: Occurrence of Multiple Emerging Phthalate Alternatives and Their Metabolites in Human Milk and Implications for Combined Exposure in Infants

Phthalate Exposure Pattern in Breast Milk within a Six-Month Postpartum Time in Southern Taiwan

GC-MS Analysis of Phthalates and Di-(2-thylhexyl) Adipate in Canadian Human Milk for Exposure Assessment of Infant Population

Cumulative Exposure to Phthalates and Their Alternatives and Associated Female Reproductive Health: Body Burdens, Adverse Outcomes, and Underlying Mechanisms

Occurrence of Multiple Classes of Emerging Synthetic Antioxidants, Including p -Phenylenediamines, Diphenylamines, Naphthylamines, Macromolecular Hindered Phenols, and Organophosphites, in Human Milk: Implications for Infant Exposure

DNA oxidative damage in pregnant women upon exposure to conventional and alternative phthalates

Human exposure, hazard and risk of alternative plasticizers to phthalate esters

Occurrence of Multiple Bisphenol S Derivatives in Breast Milk from Chinese Lactating Women and Implications for Exposure in Breast-fed Infants

Are New Phthalate Ester Substitutes Safer Than Traditional DBP and DiBP? Comparative Endocrine-Disrupting Analyses on Zebrafish Using in Vivo, Transcriptome, and in Silico Approaches.

[Cumulative Risk Assessment of Phthalates Exposure among Infants and Their Mothers in Shanghai].

Phthalate metabolites in meconium and their associations with hormones in cord blood

Exploring diet as a source of plasticizers in pregnancy and implications for maternal second-trimester metabolic health

Assessment on cumulative health risk of phthalic acid esters in meconium of 237 Shanghai newborns

Organophosphate ester and phthalate ester metabolites in urine from primiparas in Shenzhen, China: Implications for health risks

Exposure Levels of Environmental Endocrine Disruptors in Mother-Newborn Pairs in China and Their Placental Transfer Characteristics

Ongoing exposure to endocrine disrupting phthalates and alternative plasticizers in neonatal intensive care unit patients

Neonatal exposure to phthalate and alternative plasticizers via parenteral nutrition

Lactational exposure to phthalates impaired the neurodevelopmental function of infants at 9 months in a pilot prospective study

Phthalate concentrations in personal care products and the cumulative exposure to female adults and infants in Shanghai.

The effects of phthalate ester exposure on human health: A review

Exposure and potential risks of thirteen endocrine- disrupting chemicals in pharmaceuticals and personal care products for breastfed infants in China